The purpose of this study is to determine if inflammation, i.e. VCAM-1 expression, is a better diagnostic tool of early plaque development than other markers of atherosclerosis, including EDD, and in addition if peripheral VCAM-1 can predict the extent of CAD. This evidence concerns the gene VCAM1 and atherosclerosis.